Managed Healthcare Executive August 15, 2022
Peter Wehrwein

Findings from a cros-sectional study reported by Yale and Mount Sinai researchers last week in a preprint last week linked long COVID to low levels of cortisol, the stress hormone, and possibly to reactivation of latent Epstein-Barr virus infections. Eric Topol called the study one of the best of long COVID so far.

Long COVID affects a sizable percentage (there is a lot of uncertainty about the exact proportion) of people who get COVID-19. The symptoms vary but among the most common are persistent fatigue, “brain fog,” cognitive impairment and symptoms that get worse after physical or mental effort, sometimes referred to as post-exertional malaise.

There are lots of theories, but the causes of long COVID are far clear. But...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
The Ripple Effect: Ways to Make Health in All Policies Stick in Kansas and Beyond to Enhance Health and Equity
Research Funding Is Needed To Support An Effective, Equitable, And Sustainable Public Health System
Covid’s scientific silver lining: A chance to watch the human immune system respond in real time
New Data: Long COVID Cases Surge
New federal health IT strategy increases focus on public health, AI

Share This Article